For research use only. Not for therapeutic Use.
Vascular endothelial growth factor receptor 2 (VEGFR2, also known as KDR and FLK1) is a receptor tyrosine kinase that regulates angiogenesis, vascular development, and embryonic hematopoiesis in response to VEGF isoforms A, C, and D. VEGFR2 kinase inhibitor I is a potent, cell-permeable inhibitor of mouse VEGFR2 kinase (IC<sub>50</sub> = 70 nM). It has little or no effect against receptors for platelet-derived growth factor, epidermal growth factor, or insulin-like growth factor (IC<sub>50</sub> > 100 µM).
Catalog Number | M137895 |
CAS Number | 15966-93-5 |
Synonyms | SU 5408 |
Molecular Formula | C18H18N2O3 |
Purity | ≥95% |
Target | VEGFR |
Storage | -20°C |
IUPAC Name | ethyl 2,4-dimethyl-5-[(2-oxo-1H-indol-3-ylidene)methyl]-1H-pyrrole-3-carboxylate |
InChI | InChI=1S/C18H18N2O3/c1-4-23-18(22)16-10(2)15(19-11(16)3)9-13-12-7-5-6-8-14(12)20-17(13)21/h5-9,19H,4H2,1-3H3,(H,20,21) |
InChIKey | PMUJUSJUVIXDQC-UHFFFAOYSA-N |
SMILES | CCOC(=O)C1=C(NC(=C1C)C=C2C3=CC=CC=C3NC2=O)C |